口服接种分泌LTB融合病毒蛋白的活菌对禽冠状病毒的保护作用
本研究设计并评估了一种抗传染性支气管炎病毒(IBV)疫苗,由表达并分泌与热不稳定肠毒素B(LTB)融合的病毒刺突1亚单位(S1)及核衣壳N端和C端多肽(分别为LS1、LNN、LNC)的大肠杆菌组成。鸡口服接种后,在加强免疫后14天评估抗IBV IgY水平、细胞免疫及对强毒IBV攻击的保护。口服接种诱导的IgY水平超过分别接种各组分后的水平;攻击后3天起,接种鸡的病毒载量和排毒鸡百分比显著降低。
要点
- 口服表达LTB融合IBV多肽的细菌诱导病毒特异性IgY抗体产生。
- 口服接种LNN或LNC细菌的鸡脾细胞CD8+细胞百分比高于对照及皮下接种组。
- 攻击强毒IBV后,接种鸡病毒载量和排毒鸡百分比自第3天起显著降低。
核心结论
- 口服表达LTB融合IBV多肽的细菌诱导病毒特异性IgY抗体产生,并与强毒IBV攻击后排毒时间显著缩短相关。
研究设计与样本
- 设计并评估由表达并分泌LTB融合IBV S1、N端和C端多肽的大肠杆菌组成的抗IBV疫苗,进行鸡口服接种实验。
主要发现
- 口服接种诱导的IgY水平超过分别接种各组分后的水平。
- 口服接种LNN或LNC表达细菌的鸡脾细胞CD8+细胞百分比高于接种野生型或分泌LTB的大肠杆菌组及皮下接种组。
- 攻击107.5 EID50/ml强毒IBV后3天起,接种鸡的病毒载量和排毒鸡百分比显著降低。
临床怎么用
- 作者认为该疫苗设计和接种途径有望成为保护家禽养殖场免受传染性支气管炎暴发的有效且快速可适配的手段。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The devastating impact of infectious bronchitis (IB) triggered by the IB virus (IBV), on poultry farms is generally curbed by livestock vaccination with live attenuated or inactivated vaccines. Yet, this approach is challenged by continuously emerging variants and by time limitations of vaccine preparation techniques. This work describes the design and evaluation of an anti-IBV vaccine comprised of E. coli expressing and secreting viral spike 1 subunit (S1) and nucleocapsid N-terminus and C-terminus polypeptides fused to heat-labile enterotoxin B (LTB) (LS1, LNN, LNC, respectively). Following chicken oral vaccination, anti-IBV IgY levels and cellular-mediated immunity as well as protection against virulent IBV challenge, were evaluated 14 days following the booster dose. Oral vaccination induced IgY levels that exceeded those measured following vaccination with each component separately. Following exposure to inactivated IBV, splenocytes isolated from chicks orally vaccinated with LNN or LNC -expressing bacteria, showed a higher percentage of CD8+ cells as compared to splenocytes isolated from chicks vaccinated with wild type or LTB-secreting E. coli and to chicks subcutaneously vaccinated. Significant reduction in viral load and percent of shedders in the vaccinated chicks was evident starting 3 days following challenge with 107.5 EID50/ml virulent IBV. Taken together, orally delivered LTB-fused IBV polypeptide-expressing bacteria induced virus-specific IgY antibody production and was associated with significantly shorter viral shedding on challenge with a live IBV. The proposed vaccine design and delivery route promise an effective and rapidly adaptable means of protecting poultry farms from devastating IB outbreaks.
引用
- Lublin A, Katz C, Gruzdev N, et al. Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins. Vaccine. 2021. PMID: 34998606. doi:10.1016/j.vaccine.2021.12.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。